UNSPSC 51294522: Paroxetine maleate

This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C19H20FNO3.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F726G2563Q, chemically known as (3s,4r)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine maleate, but more generally known as paroxetine maleate, which bears US NIH Compound Identifier 6435921.

European Medicines Agency schedules paroxetine maleate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09631MIG. Most nations, for tariff purposes, schedule paroxetine maleate under HS 29349990. SMILES: C1CC(CCC1[C@@H]2CCNC[C@H]2COC3CCC4C(C3)OCO4)F.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51294522 Paroxetine maleate is a Commodity code that nominally covers a specific pharmaceutical product, but the recent state and local procurement activity tagged under this code does not reflect pharmaceutical procurement in the traditional sense. The single recent opportunity on record shows a mismatch between the code's abstract scope and what is actually being solicited: Seminole County, Florida posted an IFB for naloxone and drug deactivation systems, which are harm-reduction and emergency-response supplies rather than paroxetine or psychiatric medications. The misclassification suggests either a data-entry error in the county's tagging system or a deliberate use of the code as a placeholder for opioid-reversal and controlled-substance disposal products that may lack a more precise commodity code in the state or local system.

Seminole County's naloxone and safe drug deactivation systems solicitation (IFB 60459723LAS, due July 26, 2023) represents the available recent activity under this code. The procurement called for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The county required electronic bid submission through its e-Procurement Portal, with vendors responsible for all shipping and delivery costs. Bidders were required to meet E-Verify compliance, drug-free workplace certification, and specific insurance coverage thresholds, including workers' compensation and commercial general liability. The contract carried a two-year initial term with an optional one-year renewal and a three-month probationary termination clause. The solicitation did not name explicit set-asides for disadvantaged enterprises, though potential FEMA funding introduced additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. Given the code's pharmaceutical focus and the absence of other recent paroxetine-specific procurement activity in the source, this code sees minimal relevant state and local opportunity activity at present.